Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-29 | Mr. Robert Melvin-Douglas CrossIndependent Non-Executive Chairman | -25,00k | 99,02k | Vente | 3,96 | 51,40k | -32,72% |
| 2026-04-02 | Dr. James Andrew RobinsonPresident, COO & Director | 10,00k | 33,99k | Achat | 3,40 | 3,28M | 0,31% |
| 2026-03-31 | Mr. Salah I. GamoudiCFO | 105,80k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 2,31 | 958,62k | 12,41% |
| 2026-03-31 | Mr. Michael BarmanChief Development Officer | 72,55k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 2,31 | 837,68k | 9,48% |
| 2026-03-31 | Dr. James Andrew RobinsonPresident, COO & Director | 212,80k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 2,31 | 1,67M | 14,60% |
| 2026-03-31 | Mr. David ParkCEO & Director | 327,06k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 2,31 | 2,92M | 12,60% |
| 2026-04-01 | Dr. James Andrew RobinsonPresident, COO & Director | 10,00k | 34,85k | Achat | 3,48 | 3,27M | 0,31% |
| 2026-03-31 | Mr. David ParkCEO & Director | -505,52k | 0,00 | Other Disposition | - | 1,62M | -23,77% |
| 2026-03-30 | Mr. David ParkCEO & Director | -161,15k | 0,00 | Derivative Exercise and Sale | - | 1,62M | - |
| 2026-03-31 | Mr. David ParkCEO & Director | -2,00M | 0,00 | Other Derivative Disposition | - | 0,00 | -100,00% |
| 2026-03-26 | Mr. Salah I. GamoudiCFO | 39,67k | 0,00 | Derivative Exercise and Retained Stock | - | 106,70k | 59,18% |
| 2026-03-26 | Ms. Karen G. NarwoldIndependent Director | 55,76k | 0,00 | Derivative Exercise and Retained Stock | - | 55,76k | - |
| 2026-03-26 | Mr. Michael BarmanChief Development Officer | 15,25k | 56,58k | Derivative Exercise and Retained Stock | 3,71 | 159,60k | 10,57% |
| 2026-03-26 | Dr. James Andrew RobinsonPresident, COO & Director | 40,71k | 0,00 | Derivative Exercise and Retained Stock | - | 3,26M | 1,27% |
| 2026-02-03 | Mr. David ParkCEO & Director | 111,86k | 499,82k | Achat | 4,47 | 1,46M | 8,30% |
| 2026-01-27 | Mr. Robert Melvin-Douglas CrossIndependent Non-Executive Chairman | -100,00k | 540,62k | Derivative Exercise and Sale | 5,41 | 76,40k | - |
| 2026-01-15 | Mr. Jeffrey BarberIndependent Director | 200,00k | 0,00 | Derivative Exercise and Retained Stock | - | 630,00k | 46,51% |
| 2026-01-12 | Dr. James Andrew RobinsonPresident, COO & Director | 75,93k | 0,00 | Derivative Exercise and Retained Stock | - | 3,22M | 2,42% |
| 2026-01-12 | Dr. James Andrew RobinsonPresident, COO & Director | -124,08k | 636,48k | Derivative Exercise and Sale | 5,13 | 3,22M | - |
| 2025-12-18 | Mr. David ParkCEO & Director | 50,88k | 1,88B | Derivative Exercise and Retained Stock | 36,97k | 1,35M | 3,92% |
| 2025-12-18 | Dr. James Andrew RobinsonPresident, COO & Director | 21,75k | 0,00 | Derivative Exercise and Retained Stock | - | 3,14M | 0,70% |
| 2025-12-18 | Dr. James Andrew RobinsonPresident, COO & Director | -25,20k | 126,48k | Derivative Exercise and Sale | 5,02 | 3,14M | - |
| 2025-12-18 | Mr. Salah I. GamoudiCFO | 19,40k | 0,00 | Derivative Exercise and Retained Stock | - | 67,03k | 40,74% |
| 2025-12-18 | Mr. Salah I. GamoudiCFO | -6,27k | 31,49k | Derivative Exercise and Sale | 5,02 | 67,03k | - |
| 2025-12-18 | Mr. Michael BarmanChief Development Officer | 8,15k | 0,00 | Derivative Exercise and Retained Stock | - | 144,34k | 5,98% |
| 2025-12-18 | Mr. Michael BarmanChief Development Officer | -9,45k | 47,46k | Derivative Exercise and Sale | 5,02 | 144,34k | - |
| 2025-12-09 | Mr. Robert Melvin-Douglas CrossIndependent Non-Executive Chairman | -200,00k | 954,94k | Derivative Exercise and Sale | 4,77 - 4,78 | 76,40k | - |
| 2025-11-12 | Mr. David ParkCEO & Director | 296,50k | 997,84k | Achat | 3,28 - 3,37 | 1,30M | 29,64% |
| 2025-10-09 | Mr. Robert Melvin-Douglas CrossIndependent Non-Executive Chairman | -75,00k | 342,03k | Vente | 4,45 - 4,61 | 76,40k | -49,54% |
| 2025-09-29 | Mr. Robert Melvin-Douglas CrossIndependent Non-Executive Chairman | -100,00k | 348,58k | Vente | 3,49 | 151,40k | -39,78% |
| 2025-09-29 | Dr. James Andrew RobinsonPresident, COO & Director | -220,14k | 744,48k | Derivative Exercise and Sale | 3,38 | 3,12M | - |
| 2025-09-29 | Dr. James Andrew RobinsonPresident, COO & Director | 229,86k | 0,00 | Derivative Exercise and Retained Stock | - | 3,12M | 7,96% |
| 2025-09-05 | Mr. Robert Melvin-Douglas CrossIndependent Non-Executive Chairman | -75,00k | 225,01k | Vente | 3,00 | 251,40k | -22,98% |
| 2025-08-09 | Mr. Michael BarmanChief Development Officer | 44,19k | 0,00 | Derivative Exercise and Retained Stock | - | 136,19k | 48,04% |
| 2025-08-12 | Dr. James Andrew RobinsonPresident, COO & Director | -67,58k | 190,60k | Disposition Under Employee Benefit Plan | 2,82 | 2,89M | -2,29% |
| 2025-08-12 | Mr. Salah I. GamoudiCFO | -16,82k | 47,44k | Disposition Under Employee Benefit Plan | 2,82 | 47,63k | -26,10% |
| 2025-08-09 | Dr. James Andrew RobinsonPresident, COO & Director | 117,49k | 0,00 | Derivative Exercise and Retained Stock | - | 2,89M | 4,24% |
| 2025-08-09 | Mr. Salah I. GamoudiCFO | 64,45k | 0,00 | Derivative Exercise and Retained Stock | - | 47,63k | -383,17% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
